In this presentation, Dr. Paul Links discusses options for the pharmacologic management of borderline personality disorder. He also reviews the evidence for more novel agents, such as omega-3 fatty acids, oxytocin, and buprenorphine. Finally, he presents the role of good psychiatric management in treating patients with borderline personality disorder and a variety of clinical vignettes explaining how to approach each case.
- Provider:Medical Academy, LLC
- Activity Link: https://psychopharmacologyinstitute.com/publication/pharmacologic-management-of-bpd-recent-developments-2633?utm_source=PARS+ACCME&utm_medium=PARS+ACCME&utm_campaign=PARS+ACCME
- Start Date: 2022-04-01 05:00:00
- End Date: 2022-04-01 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.5 hours
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Learner Performance
- Provider Ship: Jointly Provided
- Registration: Limited
Subscribe
Login
0 Comments
Oldest